Hypnosis upregulates the expression of immune-related genes in lymphocytes

Psychotherapy and Psychosomatics

Volumn 77, Issue 4, 2008, Pages 257-259

  Kovacs Z A ^a   Puskas L G ^b   Juhasz A ^a   Rimanoczy A ^a   Hackler Jr , L ^b   Katay L ^a   Gali, Z ^a   Vetro A ^a   Janka, Z ^a   Kalman J ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 5; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 9;

ADOLESCENT; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN EXPERIMENT; HYPNOSIS; IMMUNE SYSTEM; IMMUNOMODULATION; LETTER; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOTHERAPY; UPREGULATION;

4-1BB LIGAND; CYCLOOXYGENASE 2; CYTOKINES; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPNOSIS; LYMPHOCYTES; MALE; PSYCHONEUROIMMUNOLOGY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 43649096496     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128165     Document Type: Letter

References (23)

1. Zachariae R, Bjerring P, Zachariae C, Arendt-Nielsen L, Nielsen T, Eldrup E: Monocyte chemotactic activity in sera after hypnotically induced emotional states. Scand J Immunol 1991;34:71-79.
2. Hall HR, Mumma GH, Longo S, Dixon R: Voluntary immunomodulation: a preliminary study. Int J Neurosci 1992;63:275-285.
3. Ruzyla-Smith P, Barabasz A, Barabasz M, Warner D: Effects of hypnosis on the immune response: B-cells, T-cells, helper and suppressor cells. Am J Clin Hypn 1995;38:71-79.
4. Hewson-Bower B, Drummond PD: Secretory immunoglobulin A increases during relaxation in children with and without recurrent upper respiratory tract infections. J Dev Behav Pediatr 1996;17:311-316.
5. Gruzelier J, Smith F, Nagy A, Henderson D: Cellular and humoral immunity, mood and exam stress: the influences of self-hypnosis and personality predictors. Int J Psychophysiol 2001;42:55-71.
6. Sobrinho LG, Simoes M, Barbosa L, Raposo JF, Pratas S, Fernandes PL: Cortisol, prolactin, growth hormone and neurovegetative responses to emotions elicited during a hypnoidal state. Psychoneuroendocrinology 2003;28:1-17.
7. Wood GJ, Bughi S, Morrison J, Tanavoli S, Tanavoli S, Zadeh HH: Hypnosis, differential expression of cytokines by T-cell subsets, and the hypothalamo-pituitary-adrenal axis. Am J Clin Hypn 2003;45:179-196.
8. Hidderley M, Holt M: A pilot randomized trial assessing the effects of autogenic training in early stage cancer patients in relation to psychological status and immune system responses. Eur J Oncol Nurs 2004;8:61-65.
9. Taylor DN: Effects of a behavioral stress-management program on anxiety, mood, self-esteem, and T-cell count in HIV-positive men. Psychol Rep 1995;76:451-457.
10. Whitehouse WG, Dinges DF, Orne EC, Keller SE, Bates BL, Bauer NK: Psychosocial and immune effects of self-hypnosis training for stress management throughout the first semester of medical school. Psychosom Med 1996;58:249-263.
11. Gruzelier JH: A review of the impact of hypnosis, relaxation, guided imagery and individual differences on aspects of immunity and health. Stress 2002;5:147-163.
12. Kiecolt-Glaser JK, Marucha PT, Atkinson C, Glaser R: Hypnosis as a modulator of cellular immune dysregulation during acute stress. J Consult Clin Psychol 2001;69:674-682.
13. Padgett DA, Glaser R: How stress influences the immune response. Trends Immunol 2003;24:444-448.
14. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R: Emotions, morbidity and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002;53:83-107.
15. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R: Psychoneuroimmunology: psychological influences on immune function and health. J Couns Clin Psychol 2002;70:537-547.
16. Hayley S, Poulter MO, Merali Z, Anisman H: The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005;135:659-678.
17. Shor RE, Orne EC: Norms on the Harvard group scale of hypnotic susceptibility, form A. Int J Clin Exp Hypn 1963;11:39-47.
18. Covelli V, Passeri ME, Leogrande D, Jirillo E, Amati L: Drug targets in stress-related disorders. Curr Med Chem 2005;12:1801-1809.
19. Rothenberg ME, Hogan SP: The eosinophil. Annu Rev Immunol 2006;24:147-174.
20. Funakoshi H, Nakamura T: Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003;327:1-23.
21. Kalman J, Palotas A, Juhasz A, Rimanoczy A, Hugyecz M, Kovacs Z: Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression - evolution of antidepressants and the role of the 'neuro-immune' system. Neurochem Res 2005;30:1429-1438.
22. Valentine AD, Meyers CA: Neurobehavioral effects of interferon therapy. Curr Psychiatry Rep 2005;7:391-395.
23. Platzer C, Docke W, Volk H, Prosch S: Catecholamines trigger IL-10 release in acute systematic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 2000;105:31-38.